Meet the Authors

Patrick Hillan

Principal, Science and Strategy

Chris Zealey

Principal, Science and Strategy

Redefining the Treatment Paradigm in Mental Health

Strategic Approach to Market Entry and Paradigm Shift for a New Mental Health Therapy

Introduction

Our client was preparing to launch a new product for treatment for a mental health disorder with a unique MOA and frequency of administration, differing from the current standard of care. 

The Problem

Entering a competitive and entrenched market, they faced challenges in identifying target audiences and crafting key messages. A comprehensive communication strategy was needed to prepare the market for launch and educate on the disease state and new therapy. Our client aimed to change how providers saw the disease to change how they would treat it.

    Our Solution

    • Facilitated virtual sessions with KOLs to gather insights for the scientific narrative and communication strategy
    • Devised a communication strategy with aligned key messages
    • Identified target healthcare providers and created a detailed activity grid, outlining publications, symposia, conferences, and field activities
    • Developed guidance documents aligned to the provider perspectives to standardize the scientific narrative across the organization
    • Created core slide decks for field use to facilitate discussions and communicate the new treatment paradigm

    Value Delivered

    • Crafted unified communication strategy by integrating KOL insights, aligning with stakeholder needs
    • Created guidance documents and core decks to ensure consistent messaging and effective healthcare provider discussions
    • Optimized outreach and story support with a detailed activity grid
    Herspiegel SSG Redefining the Treatment Paradigm in Mental Health

    Learn how we crafted a compelling narrative and cost-effective strategy to boost ROI

    Meet the Authors

    Patrick Hillan

    Principal, Science and Strategy

    Chris Zealey

    Principal, Science and Strategy

    Let's Talk

    Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.